CSL Limited publishes first Corporate Responsibility Report

CSL Limited publishes first Corporate Responsibility Report

Melbourne, Australia — 30/03/2010

CSL Limited (ASX:CSL), Australia’s leading biopharmaceutical company, has released its first Corporate Responsibility Report, combining information about the Company’s economic, social and environmental performance for 2009.

“CSL has experienced significant growth over the past 10 years, which has been underpinned by our commitment to conducting our business ethically and actively contributing to the well-being of our communities,” said Dr. Brian McNamee, CEO and Managing Director of CSL Limited. “Our first Corporate Responsibility Report is an important demonstration of this ongoing commitment.”

The report details CSL’s approach to and performance in key areas of corporate responsibility. These include the Company’s research into new medicines, its ongoing success in ensuring the safety and quality of its broad portfolio of therapies, providing a positive and healthy work environment for CSL employees, behaving responsibly in the global marketplace, and providing charitable support for communities in need around the world, while minimising the environmental impacts of its operations.


Additional Resources:
Visit the Corporate Responsibility web page
Download a copy of Our Corporate Responsibility 2009 (2Mb)


Download the full release:
CSL Limited publishes first Corporate Responsibility Report (0.09Mb)


For more information please contact:

Sharon McHale
Corporate Responsibility Director
CSL Limited
Phone: +61 409 978 314